Rhamnazin, a novel inhibitor of VEGFR2 signaling with potent antiangiogenic activity and antitumor efficacy. (Q53608070)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rhamnazin, a novel inhibitor of VEGFR2 signaling with potent antiangiogenic activity and antitumor efficacy. |
scientific article |
Statements
Rhamnazin, a novel inhibitor of VEGFR2 signaling with potent antiangiogenic activity and antitumor efficacy. (English)
1 reference
Yao Yu
1 reference
Wei Cai
1 reference
Chong-gang Pei
1 reference
Yi Shao
1 reference
19 February 2015
1 reference
458
1 reference
4
1 reference
913-919
1 reference
Identifiers
1 reference